AU2003241985A1 - Dna inducing cancer cell-specific expression and cancer cell-specific expression vector - Google Patents
Dna inducing cancer cell-specific expression and cancer cell-specific expression vectorInfo
- Publication number
- AU2003241985A1 AU2003241985A1 AU2003241985A AU2003241985A AU2003241985A1 AU 2003241985 A1 AU2003241985 A1 AU 2003241985A1 AU 2003241985 A AU2003241985 A AU 2003241985A AU 2003241985 A AU2003241985 A AU 2003241985A AU 2003241985 A1 AU2003241985 A1 AU 2003241985A1
- Authority
- AU
- Australia
- Prior art keywords
- cancer cell
- specific expression
- expression vector
- dna inducing
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002160358 | 2002-05-31 | ||
JP2002-160358 | 2002-05-31 | ||
PCT/JP2003/006844 WO2003102186A1 (en) | 2002-05-31 | 2003-05-30 | Dna inducing cancer cell-specific expression and cancer cell-specific expression vector |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003241985A1 true AU2003241985A1 (en) | 2003-12-19 |
Family
ID=29706542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003241985A Abandoned AU2003241985A1 (en) | 2002-05-31 | 2003-05-30 | Dna inducing cancer cell-specific expression and cancer cell-specific expression vector |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2003102186A1 (en) |
AU (1) | AU2003241985A1 (en) |
WO (1) | WO2003102186A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998013507A1 (en) * | 1996-09-25 | 1998-04-02 | Mcgill University | Hex ii tumor-specific promoter and uses thereof in cancer therapy |
US6087164A (en) * | 1997-10-03 | 2000-07-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods and compositions for inducing tumor-specific cytotoxicity |
AU1190901A (en) * | 1999-09-30 | 2001-04-30 | Trustees Of The University Of Pennsylvania, The | Replication selective adenoviruses for use in cancer therapy |
WO2001090344A1 (en) * | 2000-05-25 | 2001-11-29 | University Of Virginia Patent Foundation | β-HCG PROMOTER BASED TUMOR-RESTRICTIVE GENE EXPRESSION FOR CANCER GENE THERAPY |
-
2003
- 2003-05-30 WO PCT/JP2003/006844 patent/WO2003102186A1/en active Application Filing
- 2003-05-30 AU AU2003241985A patent/AU2003241985A1/en not_active Abandoned
- 2003-05-30 JP JP2004510424A patent/JPWO2003102186A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2003102186A1 (en) | 2003-12-11 |
JPWO2003102186A1 (en) | 2005-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003215460A1 (en) | Cancer associated protein kinases and their uses | |
AU2002306374A1 (en) | Genes with ES cell-specific expression | |
AU2003239129A1 (en) | Methods and compositions for dna manipulation | |
EP1403366A4 (en) | Genes with es cell-specific expression | |
GB2408507B (en) | Chimeric MHC protein and oligomer thereof for specific targeting | |
AU2003220387A1 (en) | Gene amplification in cancer | |
PL376971A1 (en) | Amplified genes involved in cancer | |
AU2003212162A1 (en) | Cancer associated protein phosphatases and their uses | |
AU2003227861A1 (en) | Protein involved in cancer | |
AU2003212826A1 (en) | Cancer genes | |
AU2003241985A1 (en) | Dna inducing cancer cell-specific expression and cancer cell-specific expression vector | |
AU2003235096A1 (en) | Novel protein and dna thereof | |
AU2003299491A1 (en) | Fagopyritol synthase genes and uses thereof | |
AU2002259005A1 (en) | Compositions and methods for inducing cancer cell death | |
AU2003275946A1 (en) | Gene expression in biological conditions | |
AU2001288940A1 (en) | Gene and sequence variation associated with cancer | |
AU2002953015A0 (en) | Modified lacz gene | |
AU2002240921A1 (en) | Medane genes and proteins | |
AU2003258658A1 (en) | Improved dna and proteins | |
EP1642586A4 (en) | Cell-containing preparations | |
EP1702072A4 (en) | Genetic therapy and genetic modification using neocentromeric minichromosomes | |
AU2003262080A1 (en) | Novel protein and dna thereof | |
EP1589101A4 (en) | Novel protein and its gene | |
AU2003241762A1 (en) | Dna shuflling | |
AU2003262815A1 (en) | New tumor suppressor genes and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |